Health Minister Zweli Mkhize says selling on the vaccines will stem wasteful expenditure, but people close to the discussions with AU say they will be sold on the cheap
This content is restricted to subscribers only.
Join the M&G Community
Our commitment at the Mail & Guardian is to ensure every reader enjoys the finest experience. Join the M&G community and support us in delivering in-depth news to you consistently.
Subscribe
Subscription enables:
- – M&G community membership
- – independent journalism
- – access to all premium articles & features
- – a digital version of the weekly newspaper
- – invites to subscriber-only events
- – the opportunity to test new online features first
Already a subscriber?
Login here.
Few trials have been carried out on women expecting babies
SA’s one-million doses of the AstraZeneca vaccine will expire by early April — unless India’s Serum Institute can safely extend their use-by date.
The first batch of vaccines is almost here, but a top government adviser says achieving herd immunity by the end of the year is ‘unrealistic’
This content is restricted to subscribers only.
Join the M&G Community
Our commitment at the Mail & Guardian is to ensure every reader enjoys the finest experience. Join the M&G community and support us in delivering in-depth news to you consistently.
Subscribe
Subscription enables:
- – M&G community membership
- – independent journalism
- – access to all premium articles & features
- – a digital version of the weekly newspaper
- – invites to subscriber-only events
- – the opportunity to test new online features first
Already a subscriber?
Login here.
Full track and traceability of Covid-19 jabs won’t happen during South Africa’s vaccine roll-out, as the health department has not yet adopted the “overarching” system that would make this possible.
The department of health is also negotiating with manufacturers other than AstraZeneca to secure more than one type of vaccine
Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela that if it is successful, the company will ensure the vaccine will be available to everyone who needs it